Significance Of IGHV Mutations & How They Are Assessed episode artwork

EPISODE · Jun 21, 2016 · 2 MIN

Significance Of IGHV Mutations & How They Are Assessed

from GRACEcast · host cancerGRACE Meetings

CLL, Chronic Lymphocytic Leukemia, What is the significance of IGHV mutations and how they are assessed.  Presented by Jennifer Brown, M.D., Ph.D., Director of the CLL Center and the Dana-Farber Cancer Institute.

Episode metadata supplied by the publisher feed · Published Jun 21, 2016

Embed this episode

NOW PLAYING

Significance Of IGHV Mutations & How They Are Assessed

0:00 2:49

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of GRACEcast?

This episode is 2 minutes long.

When was this GRACEcast episode published?

This episode was published on June 21, 2016.

Can I download this GRACEcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!